Overcoming Drug Resistance in Gynecologic Cancers

Overcoming Drug Resistance in Gynecologic Cancers is a comprehensive book that provides up-to-date information on drug resistance in gynecologic cancers, including mechanisms, genetics, signaling, immunology, health disparities, nanotechnology, economic considerations, and financial impacts. It covers topics such as lifestyle, nutrition, risk factors, chemosensitizing agents, targeted therapies, immunotherapy, and genetic polymorphisms. The book is a valuable resource for cancer researchers, oncologists, clinicians, and other biomedical field members interested in improving chemotherapy outcomes for patients with gynecologic cancers.

Format: Hardback
Length: 388 pages
Publication date: 17 August 2021
Publisher: Elsevier Science Publishing Co Inc

Overcoming Drug Resistance in Gynecologic Cancers is a comprehensive and up-to-date resource that delves into the intricate mechanisms of drug resistance in gynecologic cancers, encompassing a wide range of important topics. This book provides valuable insights into the genetics, signaling, immunology, health disparities, nanotechnology, economic considerations, and financial impacts of these cancers. It goes beyond drug resistance by exploring effective strategies to reverse resistance both in the laboratory and clinic.

The book explores various aspects of gynecologic cancers, including lifestyle, nutrition, and the risk factors associated with these diseases. It also sheds light on the financial implications of drug resistance, emphasizing the significant economic burden it places on healthcare systems and patients. Chemosensitizing agents and targeted therapies are discussed in detail, highlighting their role in treating cervical, endometrial, and ovarian cancer. Immunotherapy is explored as a powerful tool to overcome drug resistance, with a focus on its potential to enhance cancer treatment outcomes.

Genetic polymorphisms in gynecologic cancers are also examined, shedding light on their role in drug response and the development of personalized treatment strategies. The book also addresses ethnic and racial health disparity perspectives, emphasizing the need for equitable access to healthcare and treatment for all patients. Furthermore, it discusses future developments in chemosensitizing activities aimed at reversing drug resistance in gynecologic cancers.

This book is a valuable resource for cancer researchers, oncologists, clinicians, and other biomedical field members who are interested in exploring innovative approaches to improve chemotherapy outcomes in patients with gynecologic cancers. It offers a comprehensive understanding of the complex factors contributing to drug resistance and provides practical strategies for combating this challenge. By leveraging the latest research and clinical expertise, Overcoming Drug Resistance in Gynecologic Cancers empowers healthcare professionals to provide optimal care and support to patients facing these challenging diseases.

Weight: 950g
Dimension: 235 x 191 (mm)
ISBN-13: 9780128242995